Palbociclib

ATC L01EF01 · 11 markets · 103 records

Palbociclib 11 markets · 103 records Forms

Filters

MarketAU 31 CA 12 US 9 GB 9 MX 7 SG 6 TW 6 ES 3 HK 3 FR 3 EU 2

Strength

Strength / form / release	US	GB	CA	AU	SG	ES	MX	TW	HK	EU	FR
125 mg tablet	Ibrance	Ibrance	Ibrance NAT-PALBOCICLIB PMS-PALBOCICLIB +1 TARO-PALBOCICLIB	Ibrance IBRANCE palbociclib 125 mg capsule blister pack PALANCE Palbociclib 100 mg tablet blister pack +2 PALBOCICLIB RBX Palbociclib 100 mg tablet blister pack PALBOCICLIB SUN Palbociclib 100 mg tablet blister pack	Ibrance	not recorded	not recorded	Ibrance 愛乳適膜衣錠125毫克	not recorded	not recorded	not recorded
100 mg tablet	Ibrance	Ibrance	Ibrance NAT-PALBOCICLIB PMS-PALBOCICLIB +1 TARO-PALBOCICLIB	Ibrance IBRANCE palbociclib 125 mg capsule blister pack PALANCE Palbociclib 100 mg tablet blister pack +2 PALBOCICLIB RBX Palbociclib 100 mg tablet blister pack PALBOCICLIB SUN Palbociclib 100 mg tablet blister pack	Ibrance	not recorded	not recorded	Ibrance 愛乳適膜衣錠100毫克	not recorded	not recorded	not recorded
75 mg tablet	Ibrance	Ibrance	Ibrance NAT-PALBOCICLIB PMS-PALBOCICLIB +1 TARO-PALBOCICLIB	Ibrance IBRANCE palbociclib 125 mg capsule blister pack PALANCE Palbociclib 100 mg tablet blister pack +2 PALBOCICLIB RBX Palbociclib 100 mg tablet blister pack PALBOCICLIB SUN Palbociclib 100 mg tablet blister pack	Ibrance	not recorded	not recorded	Ibrance 愛乳適膜衣錠75毫克	not recorded	not recorded	not recorded
125 mg capsule	Ibrance	Ibrance	not recorded	CIP PALBOCICLIB palbociclib 75 mg capsule bottle CIPALON palbociclib 75 mg capsule bottle CIPLA PALBOCICLIB palbociclib 75 mg capsule bottle +2 IBRANCE palbociclib 125 mg capsule blister pack IBRANCE palbociclib 125 mg capsule bottle	PALBONAT CAPSULES 100MG	Ibrance	not recorded	Ibrance 愛乳適膠囊125毫克	not recorded	not recorded	IBRANCE 100 mg, gélule
100 mg capsule	Ibrance	Ibrance	not recorded	CIP PALBOCICLIB palbociclib 75 mg capsule bottle CIPALON palbociclib 75 mg capsule bottle CIPLA PALBOCICLIB palbociclib 75 mg capsule bottle +2 IBRANCE palbociclib 125 mg capsule blister pack IBRANCE palbociclib 125 mg capsule bottle	PALBONAT CAPSULES 100MG	Ibrance	not recorded	Ibrance 愛乳適膠囊100毫克	not recorded	not recorded	IBRANCE 100 mg, gélule
75 mg capsule	Ibrance	Ibrance	not recorded	CIP PALBOCICLIB palbociclib 75 mg capsule bottle CIPALON palbociclib 75 mg capsule bottle CIPLA PALBOCICLIB palbociclib 75 mg capsule bottle +2 IBRANCE palbociclib 125 mg capsule blister pack IBRANCE palbociclib 125 mg capsule bottle	PALBONAT CAPSULES 100MG	Ibrance	not recorded	Ibrance 愛乳適膠囊75毫克	not recorded	not recorded	IBRANCE 100 mg, gélule
not disclosed capsule	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	APELSIN POSITIV CICLIPAL CIDAKOG +3 IBRUROL INTIARO PALFIRST	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Ibrance	not recorded	not recorded	not recorded	not recorded	Ibrance	Ibrance Palbociclib Viatris	not recorded
not disclosed tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	IBRANCE-21	not recorded	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in MX and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en MX que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 MX 有记录（未在本表显示）。另有 2 個規格/劑型僅在 MX 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

Palbociclib

AU 31 records · 6 shown of 6 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

CA 12 records · 3 shown of 3 Source Health Canada Drug Product Databas · Data as of 2026-10-23

US 9 records · 6 shown of 6 Source openFDA NDC Directory · Data as of 2026-10-23

GB 9 records · 6 shown of 6 Source NHSBSA dm+d · Data as of 2026-10-19

MX 7 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

SG 6 records · 6 shown of 6 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

TW 6 records · 6 shown of 6 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

ES 3 records · 3 shown of 3 Source CIMA (AEMPS) · Data as of live

HK 3 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

FR 3 records · 3 shown of 3 Source Base de données publique des médic · Data as of 2026-11-03

EU 2 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength